Senseera develops liquid biopsy blood tests that utilize cell-free chromatin analysis to provide detailed insights into disease processes and immune system health from a single blood sample. This technology enables early detection and monitoring of cancer and other diseases, offering patients accurate and affordable health screening solutions.
Funding
$8.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional disease detection methods often rely on invasive procedures or provide limited insight into the complex processes occurring within the body. Monitoring disease progression and treatment response can be challenging, requiring multiple tests and extended timelines.
Solution
Senseera offers a novel approach to disease monitoring through liquid biopsy blood tests, leveraging cell-free chromatin analysis. By examining fragmented chromatin in the bloodstream, Senseera's technology extracts epigenetic information to provide a comprehensive view of disease processes and immune system health. The platform combines advanced molecular biology with computational analysis, converting epigenetic data into actionable insights for disease detection and treatment monitoring. This technology enables clinicians to gain a deeper understanding of a patient's condition from a single blood sample, facilitating early detection, personalized treatment strategies, and enhanced drug development.
Target Audience
Senseera's primary target audience includes healthcare providers, researchers, and pharmaceutical companies seeking advanced tools for disease diagnosis, treatment monitoring, and drug development.
Features
- Cell-free chromatin analysis for comprehensive monitoring of human health
- Advanced molecular biology techniques to extract epigenetic information from chromatin fragments
- Computational analysis and statistical modeling to convert data into actionable insights
- Monitoring and detection of diseases and treatment response